Recent progress in the development of potential drugs against SARS-CoV-2

SARS-CoV-2, a newly emerged and highly pathogenic coronavirus, is identified as the causal agent of Coronavirus Disease (2019) (COVID-19) in the late December 2019, in China. The virus has rapidly spread nationwide and spilled over to the other countries around the globe, resulting in more than 120...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianmin, Ali, Fayaz, Khan, Imran, Zhu, Yi Zhun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
COVID-19 therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437701/
https://www.ncbi.nlm.nih.gov/pubmed/34870155
http://dx.doi.org/10.1016/j.crphar.2021.100057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437701/
https://www.ncbi.nlm.nih.gov/pubmed/34870155
http://dx.doi.org/10.1016/j.crphar.2021.100057

Ejemplares similares